摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 3'-chloro-4'-(α-D-mannopyranosyloxy)-biphenyl-4-carboxylate | 1259428-48-2

中文名称
——
中文别名
——
英文名称
methyl 3'-chloro-4'-(α-D-mannopyranosyloxy)-biphenyl-4-carboxylate
英文别名
Methyl 3'-chloro-4'-(alpha-D-mannopyranosyloxy)-biphenyl-4-carboxylate;methyl 4-[3-chloro-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzoate
methyl 3'-chloro-4'-(α-D-mannopyranosyloxy)-biphenyl-4-carboxylate化学式
CAS
1259428-48-2
化学式
C20H21ClO8
mdl
——
分子量
424.835
InChiKey
UYZZOIIIXKXPFB-JGLNRKDHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    29
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    126
  • 氢给体数:
    4
  • 氢受体数:
    8

反应信息

  • 作为反应物:
    描述:
    methyl 3'-chloro-4'-(α-D-mannopyranosyloxy)-biphenyl-4-carboxylate 在 sodium hydroxide 作用下, 以 甲醇 为溶剂, 反应 24.0h, 以222 mg的产率得到sodium 3'-chloro-4'-(α-D-mannopyranosyloxy)-biphenyl-4-carboxylate
    参考文献:
    名称:
    FimH Antagonists for the Oral Treatment of Urinary Tract Infections: From Design and Synthesis to in Vitro and in Vivo Evaluation
    摘要:
    Urinary tract infection (UTI) by uropathogenic Escherichia coli (UPEC) is one of the most common infections, particularly affecting women. The interaction of FimH, a lectin located at the tip of bacterial pill, with high mannose structures is critical for the ability of UPEC to colonize and invade the bladder epithelium. We describe the synthesis and the in vitro/in vivo evaluation of alpha-D-mannosides with the ability to block the bacteria/host cell interaction. According to the pharmacokinetic properties, a prodrug approach for their evaluation in the UTI mouse model was explored. As a result, an orally available, low molecular weight FimH antagonist was identified with the potential to reduce the colony forming units (CFU) in the urine by 2 orders of magnitude and in the bladder by 4 orders of magnitude. With FimH antagonist 16b, the great potential for the effective treatment of urinary tract infections with a new class of orally available antiinfectives could be demonstrated.
    DOI:
    10.1021/jm101011y
  • 作为产物:
    描述:
    2,3,4,6-四-O-乙酰基-α-D-吡喃甘露糖 三氯乙酰亚胺酯 在 四(三苯基膦)钯 三氟甲磺酸三甲基硅酯sodium methylatecaesium carbonate 作用下, 以 1,4-二氧六环甲醇甲苯 为溶剂, 反应 37.33h, 生成 methyl 3'-chloro-4'-(α-D-mannopyranosyloxy)-biphenyl-4-carboxylate
    参考文献:
    名称:
    [EN] MANNOSE DERIVATIVES AS ANTAGONISTS OF BACTERIAL ADHESION
    [FR] DÉRIVÉS DE MANNOSE UTILISÉS EN TANT QU'ANTAGONISTES DE L'ADHÉSION BACTÉRIENNE
    摘要:
    公开号:
    WO2011073112A3
点击查看最新优质反应信息

文献信息

  • [EN] MANNOSE PHOSPHATE DERIVATIVES AS ANTAGONISTS OF BACTERIAL ADHESION<br/>[FR] DÉRIVÉS DE MANNOSE PHOSPHATE EN TANT QU'ANTAGONISTES DE L'ADHÉSION BACTÉRIENNE
    申请人:UNIV BASEL
    公开号:WO2012164074A1
    公开(公告)日:2012-12-06
    Compounds of the formula (I) (I) wherein n is 0, 1 or 2, R1 is aryl, heteroaryl or heterocyclyl, and R2 and R3 are, independent of each other, hydrogen or a substituent as described in the specification, and one of RA, RB, RC and RD is P02(OH)2 and the other ones are hydrogen; are orally available medicaments useful for the prevention and treatment of bacterial infections, in particular of urinary infections caused by E. coli.
    公式(I)(I)化合物,其中n为0、1或2,R1为芳基、杂芳基或杂环基,R2和R3独立地为氢或如说明书中所描述的取代基,且RA、RB、RC和RD中的一个为P02(OH)2,其余为氢;是口服可用的药物,用于预防和治疗细菌感染,特别是由大肠杆菌引起的尿路感染。
  • MANNOSE DERIVATIVES AS ANTAGONISTS OF BACTERIAL ADHESION
    申请人:Ernst Beat
    公开号:US20120270824A1
    公开(公告)日:2012-10-25
    Compounds of the formula (I) wherein n is 0, 1 or 2, R 1 is aryl, heteroaryl or heterocyclyl, and R 2 and R 3 are hydrogen or a substituent as described in the specification, are useful for the prevention and treatment of bacterial infections, in particular of urinary infections caused by E. coli .
    式(I)的化合物,其中n为0、1或2,R1为芳基、杂芳基或杂环基,R2和R3为氢或规范中所述的取代基,对于预防和治疗细菌感染,特别是由大肠杆菌引起的尿路感染是有用的。
  • Mannose derivatives as antagonists of bacterial adhesion
    申请人:University of Basel
    公开号:EP2604619A2
    公开(公告)日:2013-06-19
    Compounds of the formula (I) wherein n is 0, 1 or 2, R1 is aryl, heteroaryl or heterocyclyl, and R2 and R3 are hydrogen or a substituent as described in the specification, are useful for the prevention and treatment of bacterial infections, in particular of urinary infections caused by E. coli.
    式 (I) 的化合物 其中 n 为 0、1 或 2,R1 为芳基、杂芳基或杂环基,R2 和 R3 为氢或说明书中所述的取代基,可用于预防和治疗细菌感染,特别是由大肠杆菌引起的泌尿系统感染。
  • PHENYL-ALPHA-D-MANNOSIDES FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS CAUSED BY ESCHERICHIA COLI
    申请人:University of Basel
    公开号:EP2960247A1
    公开(公告)日:2015-12-30
    Compounds of the formula (I) wherein n is 0, 1 or 2, R2 and R3 are hydrogen or a substituent as described in the specification, are useful for the prevention and treatment of bacterial infections, in particular of urinary infections caused by E. coli, wherein R1 is one of groups (B), (C), (D), (E) below:
    式(I)化合物,其中 n 为 0、1 或 2,R2 和 R3 为氢或说明书中所述的取代基,可用于预防和治疗细菌感染,特别是由大肠杆菌引起的泌尿系统感染、 其中 R1 为以下 (B)、(C)、(D)、(E) 组之一:
  • Mannose-derived antagonists of FimH useful for treating disease
    申请人:Fimbrion Therapeutics, Inc.
    公开号:US10738070B2
    公开(公告)日:2020-08-11
    The present invention relates to mannoside derivative compounds useful as inhibitors of FimH and methods for the treatment or prevention of urinary tract infection.
    本发明涉及可用作 FimH 抑制剂的甘露糖苷衍生物化合物以及治疗或预防尿路感染的方法。
查看更多